News Statement

In response to the ongoing conflict in Ukraine, Innovative Trials, a global clinical trial patient recruitment company with headquarters in the UK, has suspended all services within Russia and implemented a package of measures to support those affected, including its own staff.


Kate Shaw, founder and Chief Executive Officer of Innovative Trials, said: “As an organisation working in an industry focused on improving lives through better health, we condemn violence in all of its forms.

“We stand with the people of Ukraine and are doing all we can to help those affected by this conflict. We remain dedicated to supporting our global team, which includes providing financial, emotional and practical support to those who remain in Ukraine, and have suspended our services within Russia.

“We can’t begin to imagine how it must feel to flee your country in the wake of such terror, but we passionately want to help. We are committed to matching donations that our employees make to the Disasters Emergency Committee humanitarian appeal and are using our networks to identify qualified Ukrainians fleeing the war zone who may be a good fit for vacancies within our company. We hope a resolution to this conflict can be found quickly to avert any further tragedy. Everyone deserves to live in peace and without fear.”



About Innovative Trials

Founded in 2010, Innovative Trials works alongside pharmaceutical and clinical research organisations to ensure that patients enrol onto clinical trials in a timely manner and are fully informed of what the research will involve for themselves and their families. This enables potential new treatments to come to market as early as possible to provide alternative therapeutic options for present and future patients.

Based in Letchworth Garden City in Hertfordshire, Innovative Trials employs around 72 members of staff in the UK. The company works internationally with a further 70 people stationed overseas in 70 countries to help clinical trial researchers recruit eligible patients and keep them involved.

For more information, visit